David A. Siegel Biomea Fusion, Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 491,000 shares of BMEA stock, worth $898,530. This represents 0.0% of its overall portfolio holdings.
Number of Shares
491,000
Previous 459,500
6.86%
Holding current value
$898,530
Previous $1.78 Million
41.36%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BMEA
# of Institutions
108Shares Held
15.9MCall Options Held
229KPut Options Held
354K-
Cormorant Asset Management, LP Boston, MA3.57MShares$6.53 Million0.81% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$4.29 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.52 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.46 Million0.59% of portfolio
-
Geode Capital Management, LLC Boston, MA626KShares$1.15 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $53.6M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...